Phase 1 Study of Autologous anti-EGFRvIII synNotch Receptor Induced anti-EphA2/IL-13Rα2 CAR (E-SYNC) T Cells in Adult Participants with EGFRvIII+ Glioblastoma

Disease Name

Glioblastoma, Brain Tumor

Study Status

Date

June 13, 2024

Detail Link ( on-site link )

https://alphaclinic.ucsf.edu/phase-1-study-autologous-anti-egfrviii-synnotch-re…